Copyright: ©Author(s) 2026.
World J Stem Cells. Apr 26, 2026; 18(4): 117707
Published online Apr 26, 2026. doi: 10.4252/wjsc.v18.i4.117707
Published online Apr 26, 2026. doi: 10.4252/wjsc.v18.i4.117707
Table 1 Proteome analysis
| Accession | Protein name | Gene name | #PSM | Ratio | UCBSC (reference) | Remark |
| P09486 | SPARC | SPARC | 349 | 2.24% | 0.13% | |
| P02452 | Collagen alpha-1 (I) chain | COL1A1 | 312 | 2.00% | 0.51% | Collagen |
| P02751-1 | Isoform 1 of fibronectin | FN1 | 297 | 1.90% | 3.32% | Cytoskeleton |
| P21333 | Filamin-A | FLNA | 264 | 1.69% | 0.58% | Cytoskeleton |
| P08123 | Collagen alpha-2 (I) chain | COL1A2 | 214 | 1.37% | 0.23% | Collagen |
| P08670 | Vimentin | VIM | 207 | 1.33% | 0.74% | |
| P12111 | Collagen alpha-3 (VI) chain | COL6A3 | 204 | 1.31% | 2.31% | Collagen |
| P12109 | Collagen alpha-1 (VI) chain | COL6A1 | 187 | 1.20% | 0.56% | Collagen |
| P35555 | Fibrillin-1 | FBN1 | 180 | 1.15% | 0.72% | |
| P02461 | Collagen alpha-1 (III) chain | COL3A1 | 168 | 1.08% | 0.14% | Collagen |
| P60709 | Actin, cytoplasmic 1 | ACTB | 154 | 0.99% | 0.92% | |
| Q99715 | Collagen alpha-1 (XII) chain | COL12A1 | 150 | 0.96% | 1.04% | |
| Q15582 | Transforming growth factor-beta-induced protein ig-h3 | TGFBI | 150 | 0.96% | 0.66% | |
| A0A804HK76 | Filamin B | FLNB | 149 | 0.95% | 0.14% | |
| A0A804HII9 | Actinin alpha 1 | ACTN1 | 134 | 0.86% | 0.49% | |
| O00469-2 | Isoform 2 of procollagen-lysine, 2-oxoglutarate 5-dioxygenase 2 | PLOD2 | 131 | 0.84% | 0.12% | |
| P02787 | Serotransferrin | TF | 111 | 0.71% | ND | Iron transporter |
| O43707 | Alpha-actinin-4 | ACTN4 | 110 | 0.70% | 0.50% | |
| P04264 | Keratin, type II cytoskeletal 1 | KRT1 | 109 | 0.70% | 0.25% | |
| P68032 | Actin, alpha cardiac muscle 1 | ACTC1 | 107 | 0.69% | 0.56% | |
| P07585 | Decorin | DCN | 103 | 0.66% | 0.32% | |
| P01033 | Metalloproteinase inhibitor 1 | TIMP1 | 100 | 0.64% | 0.03% | Collagenase inhibitor |
| P08253 | 72 kDa type IV collagenase | MMP2 | 99 | 0.63% | 0.41% | |
| A0A7P0TA35 | Protein disulfide-isomerase | P4HB | 97 | 0.62% | 0.10% | |
| P05121 | Plasminogen activator inhibitor 1 | SERPINE1 | 96 | 0.62% | 0.36% | |
| P26038 | Moesin | MSN | 94 | 0.60% | 0.39% | |
| P09871 | Complement C1s subcomponent | C1S | 91 | 0.58% | 0.29% | |
| Q12841 | Follistatin-related protein 1 | FSTL1 | 91 | 0.58% | 0.06% | |
| P35908 | Keratin, type II cytoskeletal 2 epidermal | KRT2 | 90 | 0.58% | 0.21% | |
| A0A1B0GVI3 | Keratin 10 | KRT10 | 89 | 0.57% | 0.34% | |
| A0A7I2V3T0 | CD9 molecule | CD9 | 16 | 0.02% | 0.06% | Positive marker |
| F8VWK8 | Tetraspanin (fragment) | CD63 | 11 | 0.03% | 0.04% | Positive marker |
| H0YEE2 | CD81 molecule | CD81 | 20 | 0.03% | 0.07% | Positive marker |
- Citation: Tsolmon KE, Bavuu Z, Kim SS, Jeong HS, Park D, Kim YB. Hypoxia-conditioned extracellular vesicles from human amniotic membrane stem cells attenuate D-galactose-induced aging in mice. World J Stem Cells 2026; 18(4): 117707
- URL: https://www.wjgnet.com/1948-0210/full/v18/i4/117707.htm
- DOI: https://dx.doi.org/10.4252/wjsc.v18.i4.117707